Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.

doi:10.1007/s13277-014-2739-6

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Feb 2015

Jafarzadeh A, Fooladseresht H, Minaee K, Bazrafshani M R, Khosravimashizi A, Nemati M, Mohammadizadeh M, Mohammadi M M, Ghaderi A

Abstract excerpt

The receptor for CCL22 is named CCR4 that preferentially is expressed on the regulatory T cells (Treg), and accordingly, CCL22 acts as a chemoattractant for the intratumoral Treg migration. The aim of this study was to evaluate the serum CCL22 levels and a single nucleotide polymorphism (SNP) in chemokine gene, [2030 G/C (rs223818)], in patients with breast cancer. Blood samples were collected from 100 women with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alleles

Share to Breast Neoplasms

Share to Genetic Association Studies

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Neoplasm Staging

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed

Identifiers

PMID: 25722218
DOI: 10.1007/s13277-014-2739-6

Genes

CCL22
CCR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.PMID 25722218Read ↗

Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironmentSemantic proximity Read ↗

CCL22 16C/a genetic variation is not associated with breast carcinoma in Southern Iranian population.Semantic proximity Read ↗

Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism.Semantic proximity Read ↗

Correlation between CCL4 gene polymorphisms and clinical aspects of breast cancer.Semantic proximity Read ↗

CHEMOKINE SIGNALING IN BREAST CANCER: FOCUS ON CC-MOTIF CHEMOKINE LIGANDSSemantic proximity Read ↗

Associations of CXCL12 polymorphisms with clinicopathological features in breast cancer: a case-control study.Semantic proximity Read ↗

Comprehensive Analysis of CCL21 in Human Tumors:A Potential Therapeutic Target Associated with Immune InfiltrationSemantic proximity Read ↗

CCR4 C1014T and CCL22 C16A genetic variations in the Iranian patients with colorectal adenocarcinoma.Semantic proximity Read ↗

Impact of chemokines CCR5∆32, CXCL12G801A, and CXCR2C1208T on bladder cancer susceptibility in north Indian population.Semantic proximity Read ↗

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targetingSemantic proximity Read ↗

The rs1024611 in the CCL2 gene and risk of gynecological cancer in Asians: a meta-analysis.Semantic proximity Read ↗

Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.